Clinical Trial Update: NanO2 for Large Vessel Occlusion Stroke [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for NanO2 in ischemic stroke spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NanO2

Snippet

Sponsor: NuvOx LLC | Conditions: Ischemic Stroke | Phase 2, Phase 3 | Status: UNKNOWN